Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children
Clinical trial NCT02497716 · COMPLETED
Trial details
- NCT number
- NCT02497716
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2018-05-22
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.